>
-AHF LA Times Ad: ‘City Hall: Save the Clark Hotel’-Résultats financiers du deuxième trimestre 2022 Converge Technology Solutions-Dubai Electricity and Water Authority PJSC anuncia 12 080 millones de AED en ingresos y 3300 millones de ganancia neta en la primera mitad de 2022-Thermal Interface Materials Market is Riding the Wave of Growth and Expected to rise at a CAGR of 12.40% from 2022-2030-Battery Energy Storage System Market Technology Assessment and Company Profiles Analysis Report 2022-2030 | MDC Research-Battery Coating Market is Flourishing with New Technology Product Launches Across the Globe | Reveals MDC Research Study-High Performance Fluoropolymers Market | Asia Pacific (APAC) is set to Dominate the Industry – MDC Research-Advanced Lead Acid Battery Market | Increasing Data Cente Infrastructure Drive the Industry Growth Rapidly – MDC Research-Dubai Electricity and Water Authority PJSC announces AED 12.08 billion revenue and 3.30 billion net profit in the first half of 2022-Consumer Foam Market Recent Innovation and Upcoming Trends Detailed Analysis Report with Forecast to 2030 | MDC Research-Automotive Interior Materials Market | Asia Pacific is Expected to be the Largest Market during the Forecast Period, in Terms of Value – MDC Research-Oxygen Scavenger Market | Increasing Demand for Fresh and Quality Packaged Food to Drive the Market – Reveals MDC Research Study-Prime Mining Announces Financial Results-Diversified Royalty Corp. Announces Strongest Adjusted Revenue(1) Quarter in its History-Statement from Silfab Solar on Passage of Inflation Reduction Act-Olympia Financial Group Inc. Announces Second Quarter 2022 Results-Westlake Announces $500 Million Expansion of Existing Share Repurchase Program and 20% Increase in Quarterly Dividend-CHFC Celebrates the Creation of a Hydrogen Production Tax Credit in the IRA-CURC Celebrates the Enhancements to 45Q in the IRA-Liberty Gold Reports Q2 2022 Financial and Operating Results

Arcus Biosciences Announces New Employment Inducement Grants

HAYWARD, Calif.–()–Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensation Committee of the Company’s Board of Directors granted ten new employees options to purchase a total of 22,850 shares of the Company’s common stock at an exercise price per share of $24.98, which was the closing price on June 23, 2022, and restricted stock units to acquire a total of 11,425 shares of the Company’s common stock. The equity awards were granted pursuant to the Company’s 2020 Inducement Plan, which was approved by the Company’s Board of Directors in January 2020 pursuant to the “inducement exception” under NYSE Listed Company Manual Rule 303A.08.

About Arcus Biosciences

Arcus Biosciences is a clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines for people with cancer. In partnership with industry partners, patients and physicians around the world, Arcus is expediting the development of first- or best-in-class medicines against well characterized biology and pathways and studying novel, biology-driven combinations that have the potential to help people with cancer live longer. Founded in 2015, the company has expedited the development of six investigational medicines into clinical studies, including new combination approaches that target TIGIT, PD-1, the adenosine axis (CD73 and dual A2a/A2b) and most recently, HIF-2alfa. For more information about Arcus Biosciences’ clinical and pre-clinical programs, please visit www.arcusbio.com or follow us on Twitter.

Inducement PR

Source: Arcus Biosciences

Entradas relacionadas

Leave a Comment